Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
AXAccelerate Diagnostics, Inc. logo

Accelerate Diagnostics, Inc. (AXDX)

NASDAQ Capital Market · Currency in USD
$0.03 ▲ +0.00 (+0.00%)
At close: May 14, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.03
Open
$0.08
Day's Range
$0.03 – $0.08
52 Week Range
$0.01 – $2.09
Volume
13,824,707
Avg. Volume
1,856,939
Market Cap
$859.92K
Beta (5Y Monthly)
0.22
PE Ratio (TTM)
--
EPS (TTM)
-$2.15
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Accelerate Diagnostics, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
107
CEO
Jack Phillips

Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in solutions for the rapid diagnosis of critical infections, with operations spanning the United States, Europe, and the Middle East. The company's primary offering is the Accelerate Pheno system, an advanced in vitro diagnostic platform. Paired with its dedicated test kit, the Accelerate PhenoTest, this system facilitates quick identification and antimicrobial susceptibility testing (AST) for pathogens responsible for severe or healthcare-associated infections, encompassing both Gram-positive and Gram-negative organisms.

Earnings

DateEst.Actual
May 14, 2025-$0.49-$0.88Miss
Mar 21, 2025-$0.46-$0.37Beat
Nov 7, 2024-$0.47-$0.59Miss
Aug 8, 2024-$0.55-$0.50Beat
May 8, 2024-$0.72-$0.88Miss
Mar 28, 2024-$0.62-$0.89Miss

Analyst view

Rating: Hold
Buy 25% · Hold 50% · Sell 25%

Get free alerts on AXDX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.